Cost-Effectiveness of MiniMed 780G Therapy Compared with Multiple Daily Injections (MDI) with Intermittently Scanned Continuous Glucose Monitoring (isCGM) in People with Type 1 Diabetes (T1D)-A United States Perspective

被引：0

|

作者：

Kommareddi, Mallika

Wherry, Kael

机构：

来源：

DIABETES | 2023年 / 72卷

关键词：

D O I：

10.2337/db23-999-P

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

999-P

引用

收藏

页数：2

相关论文

共 50 条

[31] COST-EFFECTIVENESS OF INSULIN PUMP AND CONTINUES GLUCOSE MONITORING VERSUS MULTIPLE DAILY INJECTIONS AND SELF-MONITORING OF BLOOD GLUCOSE IN ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
Djalalov, S.
Reimbaev, T.
Nuriddinov, K.
Djabriyev, D.
Gulyamova, K.
Alimova, N.
VALUE IN HEALTH, 2019, 22 : S584 - S584
[32] COST-EFFECTIVENESS OF G5 MOBILE CONTINUOUS GLUCOSE MONITORING (CGM) COMPARED TO SELF MONITORING BLOOD GLUCOSE (SMBG) ALONE FOR TYPE 1 DIABETES (T1DM) IN THE US
Chaugule, S.
Graham, C.
VALUE IN HEALTH, 2017, 20 (05) : A245 - A246
[33] Cost-Effectiveness of Intermittently Scanned Continuous Glucose Monitoring Versus Advanced Hybrid Closed-Loop Systems in Type 1 Diabetes: Comment on Jendle et al.
Levrat-Guillen, Fleur
Ghazi, Tara
DIABETES THERAPY, 2022, 13 (05) : 1121 - 1123
[34] Cost-Effectiveness of Intermittently Scanned Continuous Glucose Monitoring Versus Advanced Hybrid Closed-Loop Systems in Type 1 Diabetes: Comment on Jendle et al.
Fleur Levrat-Guillen
Tara Ghazi
Diabetes Therapy, 2022, 13 : 1121 - 1123
[35] Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (rt-CGM) vs. Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) in Patients with Type 2 Diabetes on Multiple Daily Injections of Insulin (T2D MDI) in Canada
Alshannaq, Hamza
Norman, Gregory J.
Willis, Michael
Nilsson, Andreas
DIABETES, 2023, 72
[36] COST-UTILITY ANALYSIS OF AN ADVANCED HYBRID CLOSED-LOOP SYSTEM VS MULTIPLE DAILY INJECTION THERAPY WITH INTERMITTENTLY SCANNED CONTINUOUS GLUCOSE MONITORING IN PEOPLE WITH TYPE 1 DIABETES AND ABOVE-TARGET HBA1C IN FRANCE
Saltik, A. Z. Ozdemir
Jadat, C.
Koch, P.
Buompensiere, M.
Yu, J.
de Portu, S.
Cohen, O.
VALUE IN HEALTH, 2024, 27 (12)
[37] Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (rt-CGM) vs. Intermittent-Scanning Continuous Glucose Monitoring (is-CGM) from a US Payer Perspective in Patients with Type 2 Diabetes on Multiple Daily Injections of Insulin (PwT2D on MDI)
Alshannaq, Hamza
Norman, Gregory J.
Lynch, Peter M.
DIABETES, 2023, 72
[38] A Cost-Effectiveness Analysis of Continuous Subcutaneous Insulin Injection versus Multiple Daily Injections in Type 1 Diabetes Patients: A Third-Party US Payer Perspective
St Charles, Meaghan
Lynch, Peter
Graham, Claudia
Minshall, Michael E.
VALUE IN HEALTH, 2009, 12 (05) : 674 - 686
[39] A cost-effectiveness analysis of continuous subcutaneous insulin injection vs. multiple daily injections in type 1 diabetes patients: A third party USA payer perspective
St Charles, Meaghan E.
Lynch, Peter
Graham, Claudia
Minshall, Michael E.
DIABETES, 2008, 57 : A337 - A337
[40] Long-Term Cost-Effectiveness the Dexcom G6 Real-Time Continuous Glucose Monitoring System Compared with Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in France
Roze, Stephane
Isitt, John J.
Smith-Palmer, Jayne
Lynch, Peter
Klinkenbijl, Brigitte
Zammit, Gerald
Benhamou, Pierre-Yves
DIABETES THERAPY, 2021, 12 (01) : 235 - 246

← 1 2 3 4 5 →